Published on Web 10/02/2009
Synthesis of Highly Enantioenriched
3,4-Dihydroquinolin-2-ones by 6-Exo-trig Radical Cyclizations
of Axially Chiral r-Halo-ortho-alkenyl Anilides
David B. Guthrie, Steven J. Geib, and Dennis P. Curran*
Department of Chemistry, UniVersity of Pittsburgh, Pittsburgh, PennsylVania 15260
Received August 5, 2009; E-mail: curran@pitt.edu
Abstract: Radical cyclizations (Bu3SnH, Et3B/air, rt) of racemic R-halo-ortho-alkenyl anilides provide 3,4-
dihydroquinolin-2-ones in high yield. Cyclizations of enantioenriched precursors occur in similarly high yields
and with transfer of axial chirality to the new stereocenter of the products with exceptionally high fidelity
(often >95%). Single and tandem cyclizations of R-halo-ortho-alkenyl anilides bearing an additional
substituent on the R-carbon occur with high chirality transfer and high diastereoselectivity. Straightforward
models are proposed to interpret both the chirality transfer and diastereoselectivity aspects. These first
examples of an approach for axial chiral transfer from a reactive species in the amide to an acceptor suggest
broad potential for extension both within and beyond radical reactions.
Introduction
The dihydroquinolin-2-one ring is an important heterocycle
that is featured in both natural products and medicinally active
compounds.1 Dihydroquinolin-2-ones can exist as isolated ring
systems, as in the penigquinolones,2 pinolinone,3 R2ꢀ3 integrin
antagonists4 (see 1, Figure 1), and a class of HIV reverse
transcriptase inhibitors.5 Or, they can be conjoined with other
rings, as in scandine and the related meloscine alkaloids (see
2, Figure 1).6,7 Many methods exist to make racemic dihydro-
quinolin-2-ones, but only a few routes toward single enantiomers
have been reported.8 These methods suffer from various
drawbacks (low ee, limited generality), so new methods are
needed.
Figure 1. Representative 3,4-dihydroquinolin-2-ones with ring system
highlighted in red.
Many of the most important dihydroquinolin-2-ones have
alkyl or other substituents at the C-4 position, and convenient
ways to access such compounds in racemic form involve 6-exo-
trig cyclizations. Figure 2 shows examples of both radical9 and
ionic approaches. Jones reported that reduction of 3 with
Bu3SnH provided target dihydroquinolin-2-one 4 along with
comparable amounts of the product of 1,5-hydrogen transfer 5
in 51% combined yield.10 In this method (Approach 1), a radical
generated on the aryl ring cyclizes to an acceptor on the anilide
carbonyl group. Ikeda11 and Parsons12 took the reverse strategy
(Approach 2), generating a radical adjacent to the amide
(1) For a more complete collection of references to biologically active
3,4-dihydroquinolin-2-ones and methods of synthesis, see: Zhou, W.;
Zhang, L.; Jiao, N. Tetrahedron 2009, 65, 1982–1987.
(2) Ito, C.; Itoigawa, M.; Otsuka, T.; Tokuda, H.; Nishino, H.; Furukawa,
H. J. Nat. Prod. 2000, 63, 1344–1348.
(3) Kimura, Y.; Kusano, M.; Koshino, H.; Uzawa, J.; Fujioka, S.; Tani,
K. Tetrahedron Lett. 1996, 37, 4961–4964.
(4) (a) Ellis, D.; Kuhen, K. L.; Anaclerio, B.; Wu, B.; Wolff, K.; Yin,
H.; Bursulaya, B.; Caldwell, J.; Karanewsky, D.; He, Y. Bioorg. Med.
Chem. Lett. 2006, 16, 4246–4251. (b) Patel, M.; McHugh, R. J., Jr.;
Cordova, B. C.; Klabe, R. M.; Bacheler, L. T.; Erickson-Viitanen, S.;
Rodgers, J. D. Bioorg. Med. Chem. Lett. 2001, 11, 1943–1945.
(5) Seitz, W.; Geneste, H.; Backfisch, G.; Delzer, J.; Graef, C.; Hornberger,
W.; Kling, A.; Subkowskic, T.; Norbert, Z. Bioorg. Med. Chem. Lett.
2008, 18, 527–531.
(8) (a) El Ali, B.; Okuro, K.; Vasapollo, G.; Alper, H. J. Am. Chem. Soc.
1996, 118, 4264–4270. (b) Dong, C.; Alper, H. Tetrahedron: Asym-
metry 2004, 15, 35–40. (c) Okuro, K.; Kai, H.; Alper, H. Tetrahedron:
Asymmetry 1997, 8, 2307–2309. (d) Blay, G.; Cardona, L.; Torres,
L.; Pedro, J. R. Synthesis 2007, 108–112. (e) Bolm, C.; Hildebrand,
J. P. Tetrahedron Lett. 1998, 39, 5731–5734.
(6) Isolation: (a) Bernauer, K.; Englert, G.; Vetter, W. Experientia 1965,
21, 374–375. (b) Bernauer, K.; Englert, G.; Vetter, W.; Weiss, E. HelV.
Chim. Acta 1969, 52, 1886–1905. (c) Oberha¨nsli, W. E. HelV. Chim.
Acta 1969, 52, 1905–1911. (d) Plat, M.; Hachem-Mehri, M.; Koch,
M.; Scheidegger, U.; Potier, P. Tetrahedron Lett. 1970, 39, 3395–
3398.
(9) Other radical approaches include bimolecular additions, see ref 1, and
cyclizations to isocyanates, see: Minin, P. L.; Walton, J. C. J. Org.
Chem. 2003, 68, 2960–2963.
(10) (a) Clark, A. J.; Jones, K.; McCarthy, C.; Storey, J. M. D. Tetrahedron
Lett. 1991, 32, 2829–2832. (b) Clark, A. J.; Jones, K. Tetrahedron
1992, 48, 6875–6882. Related additions to aryl rings: (c) Lopez de
Turiso, F. G.; Curran, D. P. Org. Lett. 2005, 7, 151–154.
(11) (a) Sato, T.; Ishida, S.; Ishibashi, H.; Ikeda, M. J. Chem. Soc., Perk.
Trans. 1 1991, 353–359. (b) Ishibashi, H.; Sato, T.; Ikeda, M. Synthesis
2002, 6, 695–713.
(7) Synthesis: (a) Overman, L. E.; Robertson, G. M.; Robichaud, A. J.
J. Am. Chem. Soc. 1991, 113, 2598–2610. (b) Denmark, S. E.; Cottell,
J. J. AdV. Synth. Catal. 2006, 348, 2397–2042. (c) Selig, P.; Bach, T.
Angew. Chem., Int. Ed. 2008, 47, 5082–5084. (d) Selig, P.; Herdtweck,
E.; Bach, T. Chem.sEur. J. 2009, 15, 3509–3525.
(12) Allan, G. M.; Parsons, A. F.; Pons, J.-F. Synlett 2002, 1431–1434.
9
15492 J. AM. CHEM. SOC. 2009, 131, 15492–15500
10.1021/ja9066282 CCC: $40.75 2009 American Chemical Society